Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints leading oncologist to board

Thomas Lynch is director of Yale Cancer Center

BMS Thomas LynchBristol-Myers Squibb (BMS) has appointed one of the world's leading oncologists to its board of directors.

Dr Thomas Lynch, who is currently director of the Yale Cancer Center, will join the pharma company's science and technology committee.

In addition to his role at Yale, Dr Lynch is also physician-in-chief at the Smilow Cancer Hospital at Yale-New Haven in the US, as well as professor of medical oncology at the same hospital.

Lamberto Andreotti, CEO of BMS, praised both Dr Lynch's work in cancer as well as his business leadership.

“As we advance our work in immuno-oncology and build our leadership position in oncology, his guidance and scientific and business perspectives will be invaluable,” said Andreotti.

Prior to his current roles at Yale, Dr Lynch was a professor of medicine at Harvard Medical School and chief of haematology and oncology at Massachusetts General Hospital (MGH) Cancer Center.

He also served as director of the Center for Thoracic Cancers at MGH and director of medical oncology at MGH Thoracic Oncology Center.

13th December 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics